NAD IV Therapy In The Fight Against Opioid Addiction and Drug Addiction

Nicotinamide Adenine Dinucleotide (NAD) is a metabolic co-enzyme and is charged with the vital job of remodeling, structuring and repairing all the cells in the body. These specialized enzymes need continuous replacement in the body.  Regrettably, drug and alcohol abuse cause the human brain to reorganize, especially on a cellular level.  This process is known as “neuroadaptation” and is precisely to blame for addiction-related damage to the brain and the exhaustion of neurotransmitters.  “NAD IV therapy” is believed to restock these enzymes that are drained and target brain restoration.

How NAD treatment works

NAD IV therapy normally needs one infusion for a time period of 10 days. A physician develops an individualized treatment plan for every patient, including the exact NAD mixture.  At the beginning of each day, a nurse trained in this therapy will insert an IV and start to slowly infuse the mixture of  NAD. Withdrawal symptoms are reported to start subsiding in only a matter of minutes.  The patient can relax comfortably while the formulation is being distributed over a period of around 8 hours.  Some accounts reveal that NAD therapy can decrease symptoms of withdrawal by 70-80%.

Between 4 and 8 day

Between the 4th and 8th day, patients normally report feeling much better, with improved mental clarity.  But it is vital to note that a patient needs to complete each infusion process so to eliminate or minimize longings.  More significantly, after having this therapy, each patient must then deal with the psychological facets of addiction, otherwise, setbacks are inescapable.

Additional research and evaluation

Though NAD IV therapy needs more research and evaluation, the treatment seems to offer positive effects among patients who are struggling with addiction. There is data that is clinical of brain tissue and behavioral definite adjustments during therapy of anti-aging, addictions, and craving when using NAD as well as amino acids.  Early data indicates that the highest ratios of success rates with NAD are among opiate and alcohol addicts.




Leave a Reply